Altered lung function relates to inflammation in an acute LPS mouse model

Pulmonary Pharmacology and Therapeutics

Volumn 25, Issue 5, 2012, Pages 399-406

  Håkansson, Hanna Falk ^a   Smailagic, Amir ^a   Brunmark, Charlott ^a,b   Miller Larsson, Anna ^a   Lal, Harbans ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b AstraZeneca R and D ^*  (Sweden)

Author keywords

Acute lung injury; Chronic obstructive pulmonary disease; Glucocorticoid; Inflammation; Lipopolysaccharide; Lung function

Indexed keywords

BUDESONIDE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY PLETHYSMOGRAPHY; CELL INFILTRATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG CAPACITY; LUNG FUNCTION; LUNG LAVAGE; MEASUREMENT; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ACUTE LUNG INJURY; ANIMALS; FEMALE; FORCED EXPIRATORY VOLUME; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY MECHANICS; VITAL CAPACITY;

EID: 84865994145     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.08.001     Document Type: Article

References (40)

1. Wright J.L., Cosio M., Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008, 295:L1-15.
2. Kharitonov S.A., Sjobring U. Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. Contrib Microbiol 2007, 14:83-100.
3. Aul R, Armstrong J, Duvoix A, Lomas D, Hayes B, Miller BE et al. Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol, doi:10.1111/j.1365-2125.2012.04287.x.
4. Kabir K., Gelinas J.P., Chen M., Chen D., Zhang D., Luo X., et al. Characterization of a murine model of endotoxin-induced acute lung injury. Shock 2002, 17:300-303.
5. Matute-Bello G., Frevert C.W., Martin T.R. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008, 295:L379-L399.
6. Alm A.S., Li K., Chen H., Wang D., Andersson R., Wang X. Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice. Respir Physiol Neurobiol 2010, 171:157-164.
7. Wedzicha J.A., Seemungal T.A. COPD exacerbations: defining their cause and prevention. Lancet 2007, 370:786-796.
8. Conti G., Tambalo S., Villetti G., Catinella S., Carnini C., Bassani F., et al. Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology. Magn Reson Mat Phys Biol Med 2010, 23:93-101.
9. Sly P.D., Turner D.J., Hantos Z. Measuring lung function in murine models of pulmonary disease. Drug Discov Today Dis Models 2004, 1:337-343.
10. Vaickus L.J., Bouchard J., Kim J., Natarajan S., Remick D.G. Assessing pulmonary pathology by detailed examination of respiratory function. Am J Pathol 2010, 177:1861-1869.
11. Mathers RA, Evans GO, Bleby J, Tornow T. Total and differential leucocyte counts in rat and mouse bronchoalveolar lavage fluids using the Sysmex XT-2000iV; 2007, 16: p. 29-39.
12. Vanoirbeek J.A., Rinaldi M., De Vooght V., Haenen S., Bobic S., Gayan-Ramirez G., et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 2010, 42:96-104.
13. Faffe D.S., Seidl V.R., Chagas P.S., Goncalves de Moraes V.L., Capelozzi V.L., Rocco P.R., et al. Respiratory effects of lipopolysaccharide-induced inflammatory lung injury in mice. Eur Respir J 2000, 15:85-91.
14. Lefort J., Motreff L., Vargaftig B.B. Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation. Am J Respir Cell Mol Biol 2001, 24:345-351.
15. Menezes S.L., Bozza P.T., Neto H.C., Laranjeira A.P., Negri E.M., Capelozzi V.L., et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol 2005, 98:1777-1783.
16. Brass D.M., Hollingsworth J.W., Cinque M., Li Z., Potts E., Toloza E., et al. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol 2008, 39:584-590.
17. Olsson L.E., Smailagic A., Onnervik P.O., Hockings P.D. (1)H and hyperpolarized (3)He MR imaging of mouse with LPS-induced inflammation. J Magn Reson Imaging 2009, 29:977-981.
18. Sajjan U., Ganesan S., Comstock A.T., Shim J., Wang Q., Nagarkar D.R., et al. Elastase- and LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2009, 297:L931-L944.
19. Rojas M., Woods C.R., Mora A.L., Xu J., Brigham K.L. Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. Am J Physiol Lung Cell Mol Physiol 2005, 288:L333-L341.
20. Albaiceta G.M., Gutierrez-Fernandez A., Garcia-Prieto E., Puente X.S., Parra D., Astudillo A., et al. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. Am J Respir Cell Mol Biol 2010, 43:555-563.
21. Helyes Z., Pinter E., Sandor K., Elekes K., Banvolgyi A., Keszthelyi D., et al. Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice. Proc Natl Acad Sci U S A 2009, 106:13088-13093.
22. Quintero P.A., Knolle M.D., Cala L.F., Zhuang Y., Owen C.A. Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J Immunol 2010, 184:1575-1588.
23. Zarbock A., Allegretti M., Ley K. Therapeutic inhibition of CXCR2 by reparixin attenuates acute lung injury in mice. Br J Pharmacol 2008, 155:357-364.
24. Zeldin D.C., Wohlford-Lenane C., Chulada P., Bradbury J.A., Scarborough P.E., Roggli V., et al. Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2001, 25:457-465.
25. Schnyder-Candrian S., Quesniaux V.F., Di Padova F., Maillet I., Noulin N., Couillin I., et al. Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J Immunol 2005, 175:262-269.
26. Ghosh S., Wilson M.R., Choudhury S., Yamamoto H., Goddard M.E., Falusi B., et al. Effects of inhaled carbon monoxide on acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2005, 288:L1003-L1009.
27. Allen G., Bates J.H. Dynamic mechanical consequences of deep inflation in mice depend on type and degree of lung injury. J Appl Physiol 2004, 96:293-300.
28. Koyama S., Sato E., Nomura H., Kubo K., Miura M., Yamashita T., et al. The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 2000, 278:L658-L666.
29. Tatsumi T., Fliss H. Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am J Physiol 1994, 267:H1597-H1607.
30. Olsson L.E., Smailagic A., Onnervik P.O., Linden A., Hockings P.D. (1)H and hyperpolarized (3)He magnetic resonance imaging clearly detect the preventative effect of a glucocorticoid on endotoxin-induced pulmonary inflammation in vivo. Innate Immun 2011, 17:204-211.
31. Delayre-Orthez C., de Blay F., Frossard N., Pons F. Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy 2004, 34:1789-1795.
32. Dixon D.-, De Smet H.R., Bersten A.D. Lung mechanics are both dose and tidal volume dependant in LPS-induced lung injury. Respir Physiol Neurobiol 2009, 167:333-340.
33. Jansson A.H., Eriksson C., Wang X. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats. Vascul Pharmacol 2005, 43:101-111.
34. Rocksen D., Koch B., Sandstrom T., Bucht A. Lung effects during a generalized Shwartzman reaction and therapeutic intervention with dexamethasone or vitamin E. Shock 2004, 22:482-490.
35. Silva P.L., Garcia C.S., Maronas P.A., Cagido V.R., Negri E.M., Damaceno-Rodrigues N.R., et al. Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury. Eur Respir J 2009, 33:634-645.
36. Glaab T., Ziegert M., Baelder R., Korolewitz R., Braun A., Hohlfeld J.M., et al. Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice. Respir Res 2005, 6:139.
37. Hoymann H.G. Invasive and noninvasive lung function measurements in rodents. J Pharmacol Toxicol Methods 2007, 55:16-26.
38. Maris N.A., de Vos A.F., Dessing M.C., Spek C.A., Lutter R., Jansen H.M., et al. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005, 172:878-884.
39. Aul R., Patel S., Summerhill S., Kilty I., Plumb J., Singh D. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Int Immunopharmacol 2012, 13:225-231.
40. Thorn J. The inflammatory response in humans after inhalation of bacterial endotoxin: a review. Inflamm Res 2001, 50:254-261.